Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma

Documenti analoghi

• Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
  di: Svedsater, Henrik, et al.
  Pubblicazione: (2013)
• Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease.
  di: Thomas M Siler, et al.
  Pubblicazione: (2022-01-01)
• Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
  di: Prime, David, et al.
  Pubblicazione: (2015)
• Ease-of-use preference for the ELLIPTA(®) dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
  di: Komase, Yuko, et al.
  Pubblicazione: (2014)
• In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)
  di: Hamilton, Melanie, et al.
  Pubblicazione: (2015)